Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 513,983.0 | 469,822.0 | 386,064.0 | 280,522.0 | 232,887.0 | 177,866.0 | 135,987.0 | 107,006.0 |
Revenue growth | 9.4% | 21.7% | 37.6% | 20.5% | 30.9% | 30.8% | 27.1% | 20.2% |
Cost of goods sold | 288,831.0 | 272,344.0 | 233,307.0 | 165,536.0 | 139,156.0 | 111,934.0 | 88,265.0 | 71,651.0 |
Gross profit | 225,152.0 | 197,478.0 | 152,757.0 | 114,986.0 | 93,731.0 | 65,932.0 | 47,722.0 | 35,355.0 |
Gross margin | 43.8% | 42.0% | 39.6% | 41.0% | 40.2% | 37.1% | 35.1% | 33.0% |
Sales and marketing | 126,537.0 | 107,662.0 | 80,525.0 | 59,110.0 | 47,841.0 | 35,318.0 | 24,852.0 | 18,664.0 |
Research and development | 73,213.0 | 56,052.0 | 42,740.0 | 35,931.0 | 28,837.0 | 22,620.0 | 16,085.0 | 12,540.0 |
General and administrative | 11,891.0 | 8,823.0 | 6,668.0 | 5,203.0 | 4,336.0 | 3,674.0 | 2,432.0 | 1,747.0 |
EBITA | 12,245.0 | 25,395.0 | 23,424.0 | 15,092.0 | 12,905.0 | 4,468.0 | 4,377.0 | 2,481.0 |
EBITA margin | 2.4% | 5.4% | 6.1% | 5.4% | 5.5% | 2.5% | 3.2% | 2.3% |
Amortization of intangibles | | 512.0 | 509.0 | 565.0 | 475.0 | 366.0 | 287.0 | 270.0 |
EBIT | 12,245.0 | 24,883.0 | 22,915.0 | 14,527.0 | 12,430.0 | 4,102.0 | 4,090.0 | 2,211.0 |
EBIT margin | 2.4% | 5.3% | 5.9% | 5.2% | 5.3% | 2.3% | 3.0% | 2.1% |
Pre-tax income | -5,936.0 | 38,151.0 | 24,178.0 | 13,976.0 | 11,261.0 | 3,806.0 | 3,892.0 | 1,568.0 |
Income taxes | -3,217.0 | 4,791.0 | 2,863.0 | 2,374.0 | 1,197.0 | 769.0 | 1,425.0 | 950.0 |
Tax rate | 54.2% | 12.6% | 11.8% | 17.0% | 10.6% | 20.2% | 36.6% | 60.6% |
Net income | -2,722.0 | 33,364.0 | 21,331.0 | 11,588.0 | 10,073.0 | 3,033.0 | 2,371.0 | 596.0 |
Net margin | -0.5% | 7.1% | 5.5% | 4.1% | 4.3% | 1.7% | 1.7% | 0.6% |
|
Diluted EPS | ($0.27) | $64.78 | $41.83 | $22.99 | $20.15 | $6.15 | $4.90 | $1.25 |
Shares outstanding (diluted) | 10,189.0 | 515.0 | 510.0 | 504.0 | 500.0 | 493.0 | 484.0 | 477.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|